Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia (UltraFuture I)
Post-marketing Study in Femoral Popliteal Artery of Drug Coated Ballon Used for Treatment of Lower Limb Ischemia
Sponsor: Zhejiang Zylox Medical Device Co., Ltd.
A NA clinical study on Peripheral Arterial Disease (PAD), this trial is ongoing. The trial is conducted by Zhejiang Zylox Medical Device Co., Ltd. and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Jan 2025 — Sep 2025 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Sep 2022 — Jul 2024 [monthly]
Recruiting NA
First recorded
May 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zhejiang Zylox Medical Device Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Beijing, China , Chengde, China , Chengdu, China , Dalian, China , Guangzhou, China , Hangzhou, China , Ha’erbin, China , Lanzhou, China , Ningbo, China , Qingdao, China and 8 more locations